These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 18223219
1. Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer. Hassan S, Baccarelli A, Salvucci O, Basik M. Clin Cancer Res; 2008 Jan 15; 14(2):446-54. PubMed ID: 18223219 [Abstract] [Full Text] [Related]
2. Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Razmkhah M, Talei AR, Doroudchi M, Khalili-Azad T, Ghaderi A. Cancer Lett; 2005 Jul 28; 225(2):261-6. PubMed ID: 15978329 [Abstract] [Full Text] [Related]
6. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians. Verma R, Gupta RB, Singh K, Bhasin R, Anand Shukla A, Chauhan SS, Luthra K. J Clin Virol; 2007 Mar 28; 38(3):198-203. PubMed ID: 17240189 [Abstract] [Full Text] [Related]
7. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer. Chang SC, Lin PC, Yang SH, Wang HS, Li AF, Lin JK. Ann Surg Oncol; 2009 Aug 28; 16(8):2323-30. PubMed ID: 19472013 [Abstract] [Full Text] [Related]
8. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism. Papadopoulou E, Anagnostopoulos K, Tripsianis G, Tentes I, Kakolyris S, Galazios G, Sivridis E, Simopoulos K, Kortsaris A. Neoplasma; 2008 Aug 28; 55(3):229-38. PubMed ID: 18348656 [Abstract] [Full Text] [Related]
11. The impact of the stromal cell-derived factor-1-3'A and E-selectin S128R polymorphisms on breast cancer. Kontogianni P, Zambirinis CP, Theodoropoulos G, Gazouli M, Michalopoulos NV, Flessas J, Liberi M, Zografos GC. Mol Biol Rep; 2013 Jan 28; 40(1):43-50. PubMed ID: 23129313 [Abstract] [Full Text] [Related]
12. Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer. Teng YH, Liu TH, Tseng HC, Chung TT, Yeh CM, Li YC, Ou YH, Lin LY, Tsai HT, Yang SF. Head Neck; 2009 Oct 28; 31(10):1282-8. PubMed ID: 19373784 [Abstract] [Full Text] [Related]
14. Functional plasminogen activator inhibitor-1 gene variants and breast cancer survival. Zhang X, Shu XO, Cai Q, Ruan Z, Gao YT, Zheng W. Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6037-42. PubMed ID: 17062678 [Abstract] [Full Text] [Related]
15. Elevated plasma stromal cell-derived factor 1 protein and its gene polymorphism in patients with pelvic inflammatory disease. Tsai HT, Tee YT, Hsieh YH, Chiou HL, Lin CW, Tsai HC, Wang PH, Yang SF. Reprod Sci; 2009 Jun 15; 16(6):610-7. PubMed ID: 19282275 [Abstract] [Full Text] [Related]
16. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse. Bidard FC, Vincent-Salomon A, Gomme S, Nos C, de Rycke Y, Thiery JP, Sigal-Zafrani B, Mignot L, Sastre-Garau X, Pierga JY, Institut Curie Breast Cancer Study Group. Clin Cancer Res; 2008 Jun 01; 14(11):3306-11. PubMed ID: 18519757 [Abstract] [Full Text] [Related]
17. Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast. Liu F, Lang R, Wei J, Fan Y, Cui L, Gu F, Guo X, Pringle GA, Zhang X, Fu L. Histopathology; 2009 May 01; 54(6):741-50. PubMed ID: 19438749 [Abstract] [Full Text] [Related]
18. Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil. de Oliveira Cavassin GG, De Lucca FL, Delgado André N, Covas DT, Pelegrinelli Fungaro MH, Voltarelli JC, Watanabe MA. Blood Cells Mol Dis; 2004 May 01; 33(1):90-3. PubMed ID: 15223017 [Abstract] [Full Text] [Related]